Recurrent monomorphic epitheliotropic intestinal T ‐cell lymphoma with aberrant CD20 expression: An implication for anti‐CD20 (rituximab) antibody therapy?

Pathology International, EarlyView.

Source: Pathology International - November 6, 2018 Category: Pathology Authors: Pi ‐Han Liao, Shih‐Cheng Chou, Wan‐Ting Huang, Ying‐Zhen Su, Ming‐Chung Wang, Shih‐Sung Chuang Tags: Letter to the Editor Source Type: research